Alexion Pharmaceuticals (ALXN)
Alexion Pharmaceuticals Profit Margin: 18.56%
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
ALXN Profit Margin Rankings
| Overall | 87th percentile | 555 of 4391 |
| Sector | 89th percentile | 49 of 469 in Healthcare |
| Industry | 85th percentile | 19 of 132 in Biotechnology |
ALXN Profit Margin Range, Past 5 Years
| Minimum | -278.6% | Jun 2007 |
| Maximum | 32.13% | Sep 2011 |
| Average | -6.58% |
About Profit Margin
Profit margin represents the percentage of revenue that a company keeps as profit after accounting for fixed and variable costs. It is calculated by dividing net income by revenue. The profit margin is mainly used for internal comparisons, because acceptable profit margins vary between industries. In general, narrow profit margins indicate increased volatility. For companies with significant fixed costs, wide profit margins reduce the risk that a decline in sales will cause a net profit loss.
Displayed as a percentage, profit margin can be thought as the amount of profit that a company keeps per dollar of revenue. For example, if a company has a profit margin of 43%, the company keeps $.43 of each dollar of revenue.
Learn More
You may also be interested in these ALXN related companies
ALXN News
B/O watch over 95. Give it a bit of time to set up. $ALXN http://chart.ly/x9st6fr
about 19 hours ago by 1nvestor
about 19 hours ago by 1nvestor
$ALXN http://stks.co/3yyU ALXN is ready for a breakout, buy area is above $95
about 3 days ago by SMCHARTcom
about 3 days ago by SMCHARTcom
The weekly volume bar on $ALXN is a beauty. One of the best charts. Fundamental story strong as well
about 3 days ago by cubbiebears
about 3 days ago by cubbiebears
is the volume in $alxn simply attributed towards funds mirroring spy needing to buy?
about 3 days ago by rohitjenveja
about 3 days ago by rohitjenveja
@Momb $QCOR has been on my radar for quite some time, I will however keep an eye on $ALXN and $ARMH... :) thank you....
about 3 days ago by jfrankiep
about 3 days ago by jfrankiep
@harmongreg I've added an "Exemption" feature for stocks that don't meet all criteria but look promising for the Roll. $ALXN $BCR $CL $TSCO
about 4 days ago by 1nvestor
about 4 days ago by 1nvestor
$ALXN giving up the momentum it got from being added to the S&P 500. However, it is holding the 50-day line so far. $SPY
about 4 days ago by DarvasTrader
about 4 days ago by DarvasTrader
$ALXN In todays market, if your stock rises 5%, take the gain and run.
about 4 days ago by mmdongare
about 4 days ago by mmdongare
$ALXN up big this morning on news that it was joining the S&P 500. But fades as the day goes on. Churning. $SPY $SPX
about 5 days ago by DarvasTrader
about 5 days ago by DarvasTrader
Polo Ralph Lauren, Best Buy Included in Stocks Up on High Volume Tuesday
May 22, 12:33PM Fox Business
May 22, 12:33PM Fox Business
$ALXN nibbled a few shares @93.88. This stock was good to me before the correction.
about 5 days ago by ssmith98
about 5 days ago by ssmith98
$ALXN http://stks.co/3w7s Worth eyeing - poised to breakout to new highs
about 5 days ago by TraderFlorida
about 5 days ago by TraderFlorida
Pre-Open Movers 5/22: (EDGR) (BNHN) (RL) Higher; (EXPR) (FB0 (AZO) Lower (more...)
May 22, 9:31AM Street Insider
May 22, 9:31AM Street Insider
Alexion to Present at Bank of America Merrill Lynch 2012 Health Care Conference
May 10, 10:00AM Business Wire
May 10, 10:00AM Business Wire
Alexion to Present at Deutsche Bank Securities 37th Annual Health Care Conference
Apr 30, 10:00AM Business Wire
Apr 30, 10:00AM Business Wire
Oppenheimer updates 2012-2015 EPS Estimates on Alexion Pharmaceuticals (ALXN)
Apr 25, 2:13PM Street Insider
Apr 25, 2:13PM Street Insider
Barclays Maintains an 'Overweight' on Alexion Pharmaceuticals (ALXN); Raising PT to $104
Apr 25, 1:52PM Street Insider
Apr 25, 1:52PM Street Insider
UPDATE: Canaccord Reiterates Buy Rating, Raises PT on Alexion Pharmaceuticals
Apr 25, 11:16AM Benzinga
Apr 25, 11:16AM Benzinga
Canaccord Genuity Maintains a 'Buy' on Alexion Pharmaceuticals (ALXN); Raising PT and Estimates on Beat & Raise
Apr 25, 9:48AM Street Insider
Apr 25, 9:48AM Street Insider
UPDATE: Jefferies Raises PT to $76 on Alexion Pharmaceuticals; Maintains Hold on Lofty Valuation
Apr 25, 9:24AM Benzinga
Apr 25, 9:24AM Benzinga
Alexion Pharmaceuticals (ALXN) High Valuation: Jefferies Says Hold, Ups Price Target
Apr 25, 9:03AM Street Insider
Apr 25, 9:03AM Street Insider
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| ALXN | 92.42 | -0.68 | -0.73% | 17.19B |
| ALX | 391.06 | +0.06 | +0.02% | 1.998B |
| ALVR | 0.49 | +0.03 | +6.52% | 28.41M |
| AMNB | 22.00 | -0.24 | -1.08% | 172.26M |
| AMLP | 15.95 | +0.05 | +0.31% | |
| AMLN | 27.96 | +2.16 | +8.37% | 4.496B |
| AMKR | 4.65 | +0.07 | +1.53% | 782.83M |
| AMJ | 37.36 | +0.23 | +0.62% | |
| AMIC | 4.35 | -0.34 | -7.25% | 35.97M |
| AMGN | 69.05 | -0.05 | -0.07% | 54.16B |
